OrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024
OrthoPediatrics Corp. (Nasdaq: KIDS), a company dedicated to advancing pediatric orthopedics, has announced its schedule for releasing second quarter 2024 financial results. The company will unveil its financial performance on Monday, August 5, 2024, after the market closes. Following this, OrthoPediatrics will host a conference call on Tuesday, August 6, 2024, at 8:00 a.m. ET to discuss the results in detail.
Investors interested in the call can access a live and archived webcast of the event through the company's website at www.orthopediatrics.com, specifically on the Investors page in the Events & Presentations section. The webcast will remain available for replay for at least 90 days after the event, providing ample opportunity for stakeholders to review the information.
OrthoPediatrics Corp. (Nasdaq: KIDS), un'azienda dedicata al progresso della ortopedia pediatrica, ha annunciato il programma per la pubblicazione dei risultati finanziari del secondo trimestre 2024. L'azienda svelerà le sue performance finanziarie lunedì 5 agosto 2024, dopo la chiusura del mercato. Successivamente, OrthoPediatrics ospiterà una conference call martedì 6 agosto 2024, alle 8:00 ET per discutere i risultati in dettaglio.
Gli investitori interessati alla chiamata possono accedere a una diretta e a una registrazione dell'evento attraverso il sito web dell'azienda all'indirizzo www.orthopediatrics.com, specificamente nella pagina degli Investitori nella sezione Eventi e Presentazioni. La registrazione sarà disponibile per la riascolto per almeno 90 giorni dopo l'evento, offrendo un'ampia opportunità per gli stakeholder di esaminare le informazioni.
OrthoPediatrics Corp. (Nasdaq: KIDS), una empresa dedicada al avance de la ortopedia pediátrica, ha anunciado su cronograma para la publicación de resultados financieros del segundo trimestre de 2024. La empresa revelará su rendimiento financiero el lunes 5 de agosto de 2024, después del cierre del mercado. A continuación, OrthoPediatrics llevará a cabo una conferencia telefónica el martes 6 de agosto de 2024, a las 8:00 a.m. ET para discutir los resultados en detalle.
Los inversores interesados en la llamada pueden acceder a una transmisión en vivo y grabada del evento a través del sitio web de la empresa en www.orthopediatrics.com, específicamente en la página de Inversores en la sección de Eventos y Presentaciones. La transmisión estará disponible para reproducción durante al menos 90 días después del evento, proporcionando ample oportunidad para que las partes interesadas revisen la información.
OrthoPediatrics Corp. (Nasdaq: KIDS)는 소아 정형외과 발전에 전념하는 회사로, 2024년 2분기 재무 결과 발표 일정을 발표했습니다. 회사는 2024년 8월 5일 월요일 장 마감 후에 재무 성과를 공개합니다. 이후, OrthoPediatrics는 2024년 8월 6일 화요일 오전 8:00 ET에 결과를 상세히 논의하는 전화 회의를 진행할 예정입니다.
회의에 관심 있는 투자자는 회사 웹사이트 www.orthopediatrics.com에서 이벤트 페이지의 투자자 섹션을 통해 라이브 및 아카이브된 웹캐스트에 접근할 수 있습니다. 웹캐스트는 이벤트 후 최소 90일 동안 재생 가능하여 이해관계자들이 정보를 검토할 충분한 기회를 제공합니다.
OrthoPediatrics Corp. (Nasdaq: KIDS), une entreprise consacrée à l'avancement de l'orthopédie pédiatrique, a annoncé son calendrier de publication des résultats financiers du deuxième trimestre 2024. L'entreprise dévoilera ses performances financières le lundi 5 août 2024, après la clôture des marchés. Ensuite, OrthoPediatrics tiendra une conférence téléphonique le mardi 6 août 2024, à 8h00 ET pour discuter des résultats en détail.
Les investisseurs intéressés par la conférence peuvent accéder à une diffusion en direct et à un enregistrement de l'événement sur le site web de l'entreprise à www.orthopediatrics.com, en particulier sur la page des investisseurs dans la section Événements & Présentations. La diffusion restera disponible en replay pendant au moins 90 jours après l'événement, offrant ainsi aux parties prenantes de nombreuses possibilités de consulter les informations.
OrthoPediatrics Corp. (Nasdaq: KIDS), ein Unternehmen, das sich der Weiterentwicklung der pädiatrischen Orthopädie widmet, hat seinen Zeitplan für die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2024 bekannt gegeben. Das Unternehmen wird seine finanzielle Leistung am Montag, den 5. August 2024, nach Marktschluss bekannt geben. Anschließend wird OrthoPediatrics am Dienstag, den 6. August 2024, um 8:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse im Detail zu besprechen.
Interessierte Investoren können über die Website des Unternehmens unter www.orthopediatrics.com, speziell auf der Investoren-Seite im Bereich Veranstaltungen & Präsentationen, auf ein Live- und ein Archiv-Webcast der Veranstaltung zugreifen. Der Webcast wird für mindestens 90 Tage nach der Veranstaltung zur Wiederholung verfügbar sein, was den Stakeholdern ausreichend Gelegenheit bietet, die Informationen zu überprüfen.
- None.
- None.
WARSAW, Ind., July 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2024 financial results on Monday, August 5, 2024, after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 6, 2024, at 8:00 a.m. ET to discuss the results.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 71 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 71 countries outside the United States. For more information, please visit www.orthopediatrics.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
When will OrthoPediatrics (KIDS) release its Q2 2024 financial results?
What time is OrthoPediatrics' (KIDS) Q2 2024 earnings conference call?
How can investors access OrthoPediatrics' (KIDS) Q2 2024 earnings call?
How long will the webcast of OrthoPediatrics' (KIDS) Q2 2024 earnings call be available?
